Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Dietary fats modify vascular fat composition, eNOS localization within lipid rafts and vascular function in obesity.

Nuno DW, Coppey LJ, Yorek MA, Lamping KG.

Physiol Rep. 2018 Aug;6(15):e13820. doi: 10.14814/phy2.13820.

2.

Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity.

Murthy S, Koval OM, Ramiro Diaz JM, Kumar S, Nuno D, Scott JA, Allamargot C, Zhu LJ, Broadhurst K, Santhana V, Kutschke WJ, Irani K, Lamping KG, Grumbach IM.

PLoS One. 2017 Oct 23;12(10):e0186311. doi: 10.1371/journal.pone.0186311. eCollection 2017.

3.

Role of CaMKII in Ang-II-dependent small artery remodeling.

Prasad AM, Ketsawatsomkron P, Nuno DW, Koval OM, Dibbern ME, Venema AN, Sigmund CD, Lamping KG, Grumbach IM.

Vascul Pharmacol. 2016 Dec;87:172-179. doi: 10.1016/j.vph.2016.09.007. Epub 2016 Sep 20.

4.

Differential Regulation of Human and Mouse Myometrial Contractile Activity by FSH as a Function of FSH Receptor Density.

Stilley JA, Guan R, Santillan DA, Mitchell BF, Lamping KG, Segaloff DL.

Biol Reprod. 2016 Aug;95(2):36. doi: 10.1095/biolreprod.116.141648. Epub 2016 Jun 22.

5.

Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.

Prasad AM, Morgan DA, Nuno DW, Ketsawatsomkron P, Bair TB, Venema AN, Dibbern ME, Kutschke WJ, Weiss RM, Lamping KG, Chapleau MW, Sigmund CD, Rahmouni K, Grumbach IM.

J Am Heart Assoc. 2015 Jun 15;4(6):e001949. doi: 10.1161/JAHA.115.001949.

6.

Dietary fat, fatty acid saturation and mitochondrial bioenergetics.

Yu L, Fink BD, Herlein JA, Oltman CL, Lamping KG, Sivitz WI.

J Bioenerg Biomembr. 2014 Feb;46(1):33-44.

7.

Differential control of calcium homeostasis and vascular reactivity by Ca2+/calmodulin-dependent kinase II.

Prasad AM, Nuno DW, Koval OM, Ketsawatsomkron P, Li W, Li H, Shen FY, Joiner ML, Kutschke W, Weiss RM, Sigmund CD, Anderson ME, Lamping KG, Grumbach IM.

Hypertension. 2013 Aug;62(2):434-41. doi: 10.1161/HYPERTENSIONAHA.113.01508. Epub 2013 Jun 10.

8.

5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.

Nelson PM, Harrod JS, Lamping KG.

Exp Diabetes Res. 2012;2012:398406. doi: 10.1155/2012/398406. Epub 2012 Dec 30.

9.

RhoA localization with caveolin-1 regulates vascular contractions to serotonin.

Nuno DW, England SK, Lamping KG.

Am J Physiol Regul Integr Comp Physiol. 2012 Nov 1;303(9):R959-67. doi: 10.1152/ajpregu.00667.2011. Epub 2012 Sep 5.

10.

Modification of high saturated fat diet with n-3 polyunsaturated fat improves glucose intolerance and vascular dysfunction.

Lamping KG, Nuno DW, Coppey LJ, Holmes AJ, Hu S, Oltman CL, Norris AW, Yorek MA.

Diabetes Obes Metab. 2013 Feb;15(2):144-52. doi: 10.1111/dom.12004. Epub 2012 Sep 30.

11.

Overexpression of the SK3 channel alters vascular remodeling during pregnancy, leading to fetal demise.

Rada CC, Pierce SL, Nuno DW, Zimmerman K, Lamping KG, Bowdler NC, Weiss RM, England SK.

Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E825-31. doi: 10.1152/ajpendo.00165.2012. Epub 2012 Jul 11.

12.

Altered contribution of RhoA/Rho kinase signaling in contractile activity of myometrium in leptin receptor-deficient mice.

Harrod JS, Rada CC, Pierce SL, England SK, Lamping KG.

Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E362-9. doi: 10.1152/ajpendo.00696.2010. Epub 2011 May 10.

13.

The role of rho kinase in sex-dependent vascular dysfunction in type 1 diabetes.

Nuno DW, Lamping KG.

Exp Diabetes Res. 2010;2010:176361. doi: 10.1155/2010/176361. Epub 2010 Mar 24.

14.

Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.

Nuno DW, Harrod JS, Lamping KG.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1469-77. doi: 10.1152/ajpheart.00407.2009. Epub 2009 Aug 7.

15.

Overexpression of SK3 channels dampens uterine contractility to prevent preterm labor in mice.

Pierce SL, Kresowik JD, Lamping KG, England SK.

Biol Reprod. 2008 Jun;78(6):1058-63. doi: 10.1095/biolreprod.107.066423. Epub 2008 Feb 27.

16.

RhoA activation contributes to sex differences in vascular contractions.

Nuno DW, Korovkina VP, England SK, Lamping KG.

Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1934-40. Epub 2007 Jun 7.

PMID:
17556652
17.

Inhibition of protein kinase Cbeta protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries.

Zhou W, Wang XL, Lamping KG, Lee HC.

J Pharmacol Exp Ther. 2006 Oct;319(1):199-207. Epub 2006 Jul 21.

PMID:
16861398
18.

Cerebral vascular effects of angiotensin II: new insights from genetic models.

Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP.

J Cereb Blood Flow Metab. 2006 Apr;26(4):449-55.

PMID:
16094317
19.

Bradycardia stimulates vascular growth during gradual coronary occlusion.

Lamping KG, Zheng W, Xing D, Christensen LP, Martins J, Tomanek RJ.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2122-7. Epub 2005 Jul 28.

PMID:
16051883
20.

Responses of cerebral arterioles to ADP: eNOS-dependent and eNOS-independent mechanisms.

Faraci FM, Lynch C, Lamping KG.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2871-6.

21.

Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine.

Lamping KG, Wess J, Cui Y, Nuno DW, Faraci FM.

Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1253-8. Epub 2004 May 6.

PMID:
15130910
22.

Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels.

Chen CC, Lamping KG, Nuno DW, Barresi R, Prouty SJ, Lavoie JL, Cribbs LL, England SK, Sigmund CD, Weiss RM, Williamson RA, Hill JA, Campbell KP.

Science. 2003 Nov 21;302(5649):1416-8.

23.

Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology.

Yamada M, Basile AS, Fedorova I, Zhang W, Duttaroy A, Cui Y, Lamping KG, Faraci FM, Deng CX, Wess J.

Life Sci. 2003 Dec 5;74(2-3):345-53. Review.

PMID:
14607263
24.

M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system.

Wess J, Duttaroy A, Zhang W, Gomeza J, Cui Y, Miyakawa T, Bymaster FP, McKinzie L, Felder CC, Lamping KG, Faraci FM, Deng C, Yamada M.

Receptors Channels. 2003;9(4):279-90. Review.

PMID:
12893539
25.

Estrogen therapy induces collateral and microvascular remodeling.

Lamping KG, Christensen LP, Tomanek RJ.

Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H2039-44. Epub 2003 Jul 10.

26.

Quantification of mRNA for endothelial NO synthase in mouse blood vessels by real-time polymerase chain reaction.

Chu Y, Heistad DD, Knudtson KL, Lamping KG, Faraci FM.

Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):611-6.

PMID:
11950699
27.

Enhanced contractile mechanisms in vasospasm: is endothelial dysfunction the whole story?

Lamping KG.

Circulation. 2002 Apr 2;105(13):1520-2. No abstract available.

PMID:
11927511
28.

Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice.

Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14096-101. Epub 2001 Nov 13.

29.
30.

Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice.

Lamping KG, Nuno DW, Shesely EG, Maeda N, Faraci FM.

Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1906-12.

31.

Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice.

Lamping KG, Nuno DW, Chappell DA, Faraci FM.

Am J Physiol. 1999 Apr;276(4):R1023-9. doi: 10.1152/ajpregu.1999.276.4.R1023.

PMID:
10198381
32.

Collateral response to activation of potassium channels in vivo.

Lamping KG.

Basic Res Cardiol. 1998 Apr;93(2):136-42.

PMID:
9601581
33.

Hypercontractility of vascular muscle in atherosclerosis.

Lamping KG.

Circulation. 1997 Dec 16;96(12):4131-2. Review. No abstract available.

PMID:
9416877
34.

Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.

Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2333-40.

PMID:
9409199
35.

Response of coronary microvascular collaterals to activation of ATP-sensitive K+ channels.

Lamping KG, Nuno DW, Brooks LA, Fujii M.

Cardiovasc Res. 1997 Aug;35(2):377-83.

PMID:
9349401
36.

Response of native and stimulated collateral vessels to serotonin.

Lamping KG.

Am J Physiol. 1997 May;272(5 Pt 2):H2409-15.

PMID:
9176312
37.

Intrapericardial administration of adenovirus for gene transfer.

Lamping KG, Rios CD, Chun JA, Ooboshi H, Davidson BL, Heistad DD.

Am J Physiol. 1997 Jan;272(1 Pt 2):H310-7.

PMID:
9038951
38.

Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-1.

Lamping KG, Nuno DW.

Am J Physiol. 1996 Sep;271(3 Pt 2):H1117-24.

PMID:
8853349
39.
40.

Comparison of coronary microvascular response to nipradilol and nitroglycerin.

Lamping KG, Bloom EN.

Pharmacology. 1995 Nov;51(5):315-22.

PMID:
8584583
41.

Role of adenosine in vasodilation of epimyocardial coronary microvessels during reduction in perfusion pressure.

Komaru T, Lamping KG, Dellsperger KC.

J Cardiovasc Pharmacol. 1994 Sep;24(3):434-42.

PMID:
7528300
42.

Enhanced coronary vasoconstrictive response to serotonin subsides after removal of dietary cholesterol in atherosclerotic monkeys.

Lamping KG, Piegors DJ, Benzuly KH, Armstrong ML, Heistad DD.

Arterioscler Thromb. 1994 Jun;14(6):951-7.

PMID:
8199187
43.

Regulation of native collateral vessel dilation after coronary occlusion in the dog.

Lamping KG, Bloom EN, Harrison DG.

Am J Physiol. 1994 Feb;266(2 Pt 2):H769-78.

PMID:
8141378
44.

Effect of acute hypertension in the coronary circulation: role of mechanical factors and oxygen radicals.

De Bruyn VH, Nuno DW, Cappelli-Bigazzi M, Dole WP, Lamping KG.

J Hypertens. 1994 Feb;12(2):163-72.

PMID:
8021468
45.

Coronary microvascular response to endothelin is dependent on vessel diameter and route of administration.

Lamping KG, Clothier JL, Eastham CL, Marcus ML.

Am J Physiol. 1992 Sep;263(3 Pt 2):H703-9.

PMID:
1415594
46.

Effect of hypertension and hypertrophy on coronary microvascular pressure.

Fujii M, Nuno DW, Lamping KG, Dellsperger KC, Eastham CL, Harrison DG.

Circ Res. 1992 Jul;71(1):120-6.

PMID:
1535028
47.

Coronary microvascular response to exogenously administered and endogenously released acetylcholine.

Lamping KG, Chilian WM, Eastham CL, Marcus ML.

Microvasc Res. 1992 May;43(3):294-307.

PMID:
1635474
48.

Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium.

Kanatsuka H, Eastham CL, Marcus ML, Lamping KG.

J Cardiovasc Pharmacol. 1992 May;19(5):755-63.

PMID:
1381774
49.

Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs.

Komaru T, Lamping KG, Eastham CL, Harrison DG, Marcus ML, Dellsperger KC.

Am J Physiol. 1991 Dec;261(6 Pt 2):H2001-7.

PMID:
1750548
50.

Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses.

Komaru T, Lamping KG, Eastham CL, Dellsperger KC.

Circ Res. 1991 Oct;69(4):1146-51.

PMID:
1934341

Supplemental Content

Loading ...
Support Center